C20 C76.3
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1-Patients suffering from primary or secondary pelvic malignancies e.g. colorectal,gynaecological and urological malignancies which indicate a radical pelvic procedure in the form of TPE or APE 2-Patients should be at least 18 years old and physically and mentally fit for consent. 3-A signed consent form accepting the participation of the study shpuld be provided
Exclusion criteria
Exclusion criteria: 1-Contemporary psychiatric illness 2-Patients unwilling to consent 3-Patients participating in parallel contradicting studies. 4-Patients under immunosppressive therapy 5-Locoregional dystrophies or history of previous operations in the planned flap harvest area.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1•Length of hospital stay 2•Mortality rate amongst the patients of the two groups 3•Duration of woundhealing 4•Local complications, including: a-Donor site morbidity b-Delayed woudhealing c-Rate of flap related compications e.g. dehiscence and flap necrosis (partial and/or total) 5•Incidence of abdominal and pelvic floor herniation | — |
Secondary
| Measure | Time frame |
|---|---|
| 1-Incidence of postoperative morbidity and complications in the form of: • DVT, pulmonary embolism • Bed sores • Nosocomial infection • Sepsis 2-Assessment of the quality of life of the patients in both groups using the Short Form (36) at the 3rd and the 6th months postoperatively. 3-Assessment of the delay of a planned adjuvant therapy(chemo- or radiotherapy) because of local and/or general complications. | — |
Countries
Germany
Contacts
Universitätsklinik für Allgemein- und Viszeralchirurgie, Klinikum Oldenburg